Home > Blog > Apples to apples playing the comparability game in biotherapeutics development

Apples to Apples: Playing the Comparability Game in Biotherapeutics Development

Regulatory Consulting

Comparability studies are a significant issue for those working in biotherapeutics development, as undetected product changes are considered high risk.

Listen to the full episode on Veristat’s Advancing Revolutionary Therapies Podcast to get important insights and recommendations on how to successfully plan your clinical and CMC manufacturing development plans to reduce your regulatory risk along the way.

Learning Points

  • The importance of comparability studies for biologics
  • Key aspects of a comparability assessment
  • How to determine analytical and stability parameters when measuring comparability
  • Conditions for evaluating stability studies

LISTEN TO PODCAST

 

Meet Veristat. Learn More.

6 min read

Accelerating Patient-Centric Clinical Trials Through Science-Based Planning, Delivery and Support

May 7, 2025  Veristat Events

With 90 percent of clinical trials failing to reach completion, sponsors need innovative approaches that blend...

2 min read

ASCO Annual Meeting

Apr 23, 2025  Veristat Events

Meet Veristat at the 2025 ASCO Annual Meeting 

Advancing Oncology Therapies for Patients in Need 

Veristat is proud to...